Biomarkers like PD-L1expression and tumor-infiltrating lymphocytes (TILs), particularly CD8+ cytotoxic T lymphocytes (CTLs), are well-established indicators of ICI response (33, 106, 107). Here, CD8A is linked to neoplasm.